Risikowahrnehmung von Kontaminanten in Lebensmitteln
Sign Up to like & getrecommendations! Published in 2017 at "Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"
DOI: 10.1007/s00103-017-2557-2
Abstract: ZusammenfassungHintergrundKontaminanten in Lebensmitteln können ein ernst zu nehmendes gesundheitliches Risiko darstellen. Für eine angemessene Risikokommunikation muss auch die subjektive Risikowahrnehmung der Öffentlichkeit Berücksichtigung finden. Das weite Themenspektrum und die häufig nicht konsequent vollzogene begriffliche Trennung… read more here.
Keywords: von kontaminanten; die; kontaminanten lebensmitteln; risikowahrnehmung ... See more keywords
Bevacizumab induces oxidative cytotoxicity and apoptosis via TRPM2 channel activation in retinal pigment epithelial cells: Protective role of glutathione
Sign Up to like & getrecommendations! Published in 2021 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-021-05074-7
Abstract: Bevacizumab (BEV) is a blocker of circulating VEGF A generation. However, BEV has adverse apoptotic and cytotoxic effects via upregulation of mitochondrial reactive oxygen species (ROS) and TRPM2 activation, and downregulation of cytosolic glutathione (GSH)… read more here.
Keywords: pigment epithelial; treatment; gsh; bev ... See more keywords
Zoledronic Acid, Bevacizumab and Dexamethasone-Induced Apoptosis, Mitochondrial Oxidative Stress, and Calcium Signaling Are Decreased in Human Osteoblast-Like Cell Line by Selenium Treatment
Sign Up to like & getrecommendations! Published in 2017 at "Biological Trace Element Research"
DOI: 10.1007/s12011-017-1187-8
Abstract: Increased intracellular free calcium ion (Ca2+) concentration induces excessive oxidative stress and apoptosis. Medical procedures such as zoledronic acid (Zol), bevacizumab (Bev), and dexamethasone (Dex) are usually used in the treatment of bone diseases (osteoporosis,… read more here.
Keywords: dex; zol bev; bev; bev dex ... See more keywords
Recurrent colon perforation after discontinuation of bevacizumab for ovarian cancer
Sign Up to like & getrecommendations! Published in 2018 at "Gynecologic Oncology Reports"
DOI: 10.1016/j.gore.2018.08.005
Abstract: Bevacizumab (Bev) is an antiangiogenic drug used to treat various malignances, including ovarian cancer (OC). Bev is generally well-tolerated; however, it has a characteristic toxicity profile. In particular, gastrointestinal perforation (GIP) is a rare but… read more here.
Keywords: bevacizumab; bev; ovarian cancer; discontinuation ... See more keywords
Clinical outcomes in recurrent glioblastoma with bevacizumab therapy: An analysis of the literature
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Neuroscience"
DOI: 10.1016/j.jocn.2017.06.070
Abstract: Bevacizumab (BEV) is a common treatment for recurrent glioblastoma (GBM). After progression on BEV, there is no consensus on subsequent therapy, as multiple chemotherapy trials have failed to demonstrate discernible activity for salvage. A previous… read more here.
Keywords: therapy; bevacizumab; progression bev; bev ... See more keywords
Bevacizumab Reduces S100A9‐Positive MDSCs Linked to Intracranial Control in Patients with EGFR‐Mutant Lung Adenocarcinoma
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Thoracic Oncology"
DOI: 10.1016/j.jtho.2018.03.032
Abstract: Introduction: In vitro models have demonstrated immune‐modulating effects of bevacizumab (BEV). Combinations of an EGFR tyrosine kinase inhibitor (TKI) with BEV improve progression‐free survival (PFS) in patients with EGFR‐mutated lung adenocarcinoma. How BEV confers this… read more here.
Keywords: lung adenocarcinoma; mdscs; bev; tki group ... See more keywords
Automated flow fluorescent noncompetitive immunoassay for measurement of human plasma levels of monoclonal antibodies used for immunotherapy of cancers with KinExA™ 3200 biosensor.
Sign Up to like & getrecommendations! Published in 2019 at "Talanta"
DOI: 10.1016/j.talanta.2018.09.014
Abstract: This study describes, for the first time, the development of an automated sensitive flow fluorescent noncompetitive immunoassay based on kinetic-exclusion analysis (KinExA) for the quantitative determination of human plasma levels of monoclonal antibodies (mAbs) used… read more here.
Keywords: noncompetitive immunoassay; human plasma; bev; cet ... See more keywords
Optimum routing of battery electric vehicles: Insights using empirical data and microsimulation
Sign Up to like & getrecommendations! Published in 2018 at "Transportation Research Part D: Transport and Environment"
DOI: 10.1016/j.trd.2017.08.007
Abstract: Abstract This study investigates the energy consumption impact of route selection on battery electric vehicles (BEVs) using empirical second-by-second Global Positioning System (GPS) commute data and traffic micro-simulation data. Drivers typically choose routes that reduce… read more here.
Keywords: energy consumption; energy; electric vehicles; bev ... See more keywords
COVID-19-bezogene Ängste und deren Zusammenhang zur psychischen und physischen Gesundheit – Ergebnisse einer bevölkerungsbasierten Längsschnittstudie
Sign Up to like & getrecommendations! Published in 2024 at "Psychiatrische Praxis"
DOI: 10.1055/a-2526-2491
Abstract: Zusammenfassung Ziel der Studie In der COVID-19-Pandemie kam es zu einem Anstieg gesundheitsbezogener Ängste und Stressbelastungen. Es werden die Ausprägung COVID-19-spezifischer Ängste und Zusammenhänge zum Befinden untersucht. Methodik 2021 wurden N=321 Teilnehmende der Sächsischen Längsschnittstudie… read more here.
Keywords: ngste und; covid; der; ngste ... See more keywords
Alterations of Nutrient Elements in Hepatocellular Carcinoma Patients Treated with Atezolizumab-Bevacizumab
Sign Up to like & getrecommendations! Published in 2024 at "Nutrition and Cancer"
DOI: 10.1080/01635581.2024.2415136
Abstract: Abstract Currently, the combination of atezolizumab and bevacizumab (Atez/Bev) is recommended as the first-line therapy for patients with advanced hepatocellular carcinoma (HCC). However, there is a lack of research on the levels of nutrient elements… read more here.
Keywords: atez bev; hepatocellular carcinoma; bev; atezolizumab bevacizumab ... See more keywords
Analytical Similarity Assessment of MYL-1402O to Reference Bevacizumab.
Sign Up to like & getrecommendations! Published in 2021 at "Expert opinion on biological therapy"
DOI: 10.1080/14712598.2021.1973426
Abstract: BACKGROUND Bevacizumab (BEV) is a recombinant humanized monoclonal immunoglobulin G1 antibody that binds to vascular endothelial growth factor (VEGF)-A and acts as an antiangiogenic agent. It is approved for treatment of many cancer indications, including… read more here.
Keywords: bev; 1402o reference; analytical similarity; myl 1402o ... See more keywords